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Summary
Background.  —  Accumulating  evidence  supports  health  beneﬁts  of  dietary  ﬁbre,  such  as  improv-
ing lipid  proﬁles,  lowering  blood  pressure  and  improving  insulin  sensitivity,  but  evidence  from
comprehensive  investigation  of  dietary  ﬁbre  intake  and  mortality  from  cardiovascular  disease
(CVD) and  all  cancers  is  limited.
Aims.  —  To  quantitatively  assess  the  association  between  dietary  ﬁbre  intake  and  mortality  from
CVD and  all  cancers.
Methods.  —  We  performed  a  meta-analysis  of  prospective  cohort  studies.  Eligible  studies  were
identiﬁed  by  searching  PubMed  and  Embase  databases  for  all  articles  published  up  to  September
2014 and  via  hand  searching.  Study-speciﬁc  estimates  adjusting  for  potential  confounders  were
combined to  calculate  pooled  relative  risks  (RRs)  with  95%  conﬁdence  intervals  (CIs),  using  a
random-effects  model.
Results.  —  We  found  15  studies  that  examined  the  association  between  dietary  ﬁbre  and  mor-
tality from  CVD,  coronary  heart  disease  (CHD)  and  all  cancers.  The  pooled  RRs  of  CVD,  CHD
and all-cancer  mortality  for  the  highest  versus  lowest  category  of  dietary  ﬁbre  were  0.77
(95% CI:  0.71—0.84),  0.76  (95%  CI:  0.67—0.87)  and  0.86  (95%  CI:  0.79—0.93),  respectively.  In  a
Abbreviations: BMI, Body mass index; CI, Conﬁdence interval; CHD, Coronary heart disease; CVD, Cardiovascular disease; IHD, Ischaemic
heart disease; RR, Relative risk.
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dose-response  meta-analysis,  the  pooled  RRs  for  an  increment  of  10  g/day  in  dietary  ﬁbre  intake
were 0.91  (95%  CI:  0.88—0.94)  for  CVD,  0.89  (95%  CI:  0.85—0.93)  for  CHD  and  0.94  (95%  CI:
0.91—0.97) for  all  cancers.
Conclusions.  —  Our  ﬁndings  suggest  that  high  dietary  ﬁbre  intake  is  associated  with  a  reduced
risk of  mortality  from  CVD  and  all  cancers.  These  results  support  the  current  recommendation
that high  dietary  ﬁbre  intake  should  be  part  of  a  healthy  diet.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Justiﬁcation.  —  Des  données  convergentes  sont  en  faveur  du  bénéﬁce  des  ﬁbres  diététiques,
qui contribuent  à  améliorer  le  proﬁl  lipidique,  à  réduire  le  niveau  de  pression  artérielle  et  à
améliorer  la  sensibilité  à  l’insuline,  mais  la  preuve  de  cette  hypothèse  reste  à  démontrer  en
particulier  en  ce  qui  concerne  le  rôle  de  la  prise  de  ﬁbres  diététiques  sur  le  pronostic,  mortalité
cardiovasculaire,  en  particulier  chez  les  patients  souffrant  d’un  cancer.
Objectif.  —  Évaluer  de  fac¸on  quantitative  l’association  entre  la  consommation  des  ﬁbres  diété-
tiques et  la  mortalité  cardiovasculaire  et  par  cancer  en  utilisant  une  méthodologie  standard,
méta-analyse  des  études  de  cohortes  prospectives.
Méthode.  —  Des  études  éligibles  ont  été  identiﬁées  au  travers  d’une  recherche  PubMed  et
Embase pour  tous  les  articles  jusqu’en  septembre  2014  complétée  par  une  recherche  manuelle.
L’estimation  a  été  obtenue  après  ajustement  sur  les  variables  de  confusion,  aﬁn  de  calculer  un
risque relatif  global,  l’IC  95  %  en  utilisant  un  modèle  aléatoire.
Résultats.  —  Parmi  les  15  études  qui  ont  examiné  l’association  entre  prise  de  ﬁbres  diététiques
et mortalité  cardiovasculaire,  coronaire  et  par  cancer,  la  valeur  du  risque  relatif  de  la
mortalité en  comparant  la  consommation  la  plus  élevée  de  ﬁbres  diététiques  par  rapport  à
la consommation  la  plus  faible  était  respectivement  de  0,77  (IC  95  %  :  0,71—0,84),  0,76  (IC
95 %  :  0,67—0,87)  et  0,86  (IC  95  %  :  0,79—0,93).  Dans  une  méta-analyse  dose-réponse,  le
risque relatif  global  pour  l’augmentation  des  consommations  de  ﬁbres  diététiques  de  10  g/j
donne le  résultat  suivant  pour  le  risque  relatif  :  0,91  (IC  95  %  :  0,88—0,94)  pour  la  mortalité
cardiovasculaire  0,89  (IC  95  %  :  0,85—0,93)  pour  la  mortalité  coronaire  et  0,94  (IC  95  %  :
0,91—0,97) pour  la  mortalité  par  cancer.
Conclusion.  — Cette  méta-analyse  suggère  que  la  consommation  élevée  de  ﬁbres  diététiques  est
associée  à  une  réduction  signiﬁcative  de  la  mortalité  cardiovasculaire  et  par  cancer.  Ces  résul-
tats sont  en  faveur  d’une  recommandation  accrue  de  ﬁbres  diététiques  faisant  partie  intégrante
d’un régime  préservant  le  niveau  de  santé.
© 2015  Elsevier  Masson  SAS.  Tous  droits  réservés.
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fackground
ardiovascular  disease  (CVD)  and  cancer  are  the  leading
auses  of  death  worldwide  [1,2].  In  particular,  a  large
ortion  of  premature  deaths  (death  before  the  age  of  75
ears)  were  from  CVD  [3]  and  cancer  [2], so  we  need  to
evelop  effective  preventive  strategies  to  reduce  mortality
rom  CVD  and  cancer.  Several  modiﬁable  factors  (i.e.  smok-
ng,  physical  activity,  body  mass  index  [BMI]  and  healthy
ietary  pattern)  have  been  found  to  be  related  to  CVD  [1]
nd  cancer  [2].  Dietary  ﬁbre  is  rich  in  fruits,  vegetables  and
hole  grains,  and  consists  of  portions  of  plant  foods  that
re  edible  and  non-digestible  by  humans  [4].  Dietary  ﬁbre
ntake  is  widely  recognized  as  a  part  of  a  healthy  diet,  and
igher  intake  is  inversely  associated  with  disease  risk  factors
uch  as  dyslipidaemia,  obesity,  hypertension  and  diabetes
5].
o
f
iAccumulating  evidence  from  epidemiological  studies  has
hown  that  high  intake  of  dietary  ﬁbre  is  inversely  associ-
ted  with  the  incidence  of  CVD  (9%  reduction  in  risk  of  CVD
or  an  increase  in  dietary  ﬁbre  of  7  g  per  day)  [6].  Previous
esearch  into  dietary  ﬁbre  intake  and  CVD  focused  on  the
ncidence  of  CVD  as  an  endpoint.  Recently,  a  meta-analysis
f  prospective  cohort  studies  showed  a  signiﬁcant  inverse
ssociation  between  dietary  ﬁbre  intake  and  all-cause  mor-
ality  [7].  There  is  a growing  body  of  epidemiological  studies
n  dietary  ﬁbre  intake  and  mortality  from  CVD,  coronary
eart  disease  (CHD)  or  all  cancers  [8—22],  but  a  comprehen-
ive  assessment  of  dietary  ﬁbre  intake  and  mortality  from
VD,  CHD  and  all  cancers  has  not  been  carried  out.  There-
ore,  we  conducted  a  systematic  review  and  meta-analysis
f  prospective  cohort  studies  to  assess  the  risk  of  mortality
rom  CVD,  CHD  and  all  cancers  in  relation  to  dietary  ﬁbre
ntake  in  the  general  population.
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iDietary  ﬁbre  and  mortality  from  cardiovascular  disease  and  
Methods
Literature search and study selection
We  used  the  electronic  PubMed  and  Embase  databases  to
search  for  eligible  studies  published  in  English  up  to  Septem-
ber  2014.  The  following  key  terms  were  used  in  searching:
(‘‘ﬁbre’’  or  ‘‘ﬁbre’’)  combined  with  (‘‘cardiovascular
disease’’  or  ‘‘CVD’’  or  ‘‘coronary  disease’’  or  ‘‘CHD’’
or  ‘‘ischaemic  disease’’  or  ‘‘IHD’’  or  ‘‘cancer’’  and
‘‘mortality’’  or  ‘‘death’’).  Additionally,  we  reviewed  the
reference  lists  of  the  selected  articles  and  published  reviews
to  identify  more  studies.  We  selected  studies  according  to
following  criteria:  prospective  cohort  design;  the  exposure
of  interest  was  dietary  ﬁbre  intake;  the  outcome  of  inter-
est  was  mortality  from  CVD,  CHD,  ischaemic  heart  disease
(IHD)  or  all  cancers;  and  RRs  with  95%  conﬁdence  inter-
vals  (CIs)  were  provided.  Studies  that  reported  relative  risks
(RRs)  from  incidence  of  CVD,  CHD,  IHD  or  cancer  were  not
included.  Studies  conducted  in  patients  with  speciﬁc  dis-
eases  were  excluded.
Data extraction
Data  extraction  was  conducted  by  two  investigators  (Y.K.
and  Y.J.),  independently,  according  to  the  Meta-analysis  of
observational  studies  in  epidemiology  (MOOSE)  guidelines
[23],  and  any  discrepancies  were  resolved  by  referencing
original  articles  and  having  a  further  discussion.  The  fol-
lowing  information  was  extracted  from  each  included  study:
ﬁrst  author’s  last  name;  year  of  publication;  cohort  name;
geographical  region;  follow-up  period;  number  of  cases;
number  of  subjects  or  person-time;  adjustment  factors;  RR
and  95%  CI  for  the  association  between  various  levels  of  ﬁbre
intake  and  mortality  from  CVD,  CHD,  IHD  or  all  cancers.
We  used  the  RR  from  multivariate  models  with  the  great-
est  degree  of  adjustment  for  potential  confounders  if  the
study  reported  several  RRs  on  this  subject.
Quality assessment of individual studies
Two  investigators  (Y.K.  and  Y.J.)  independently  assessed
the  quality  of  studies  included  in  meta-analysis  by  applying
the  Newcastle-Ottawa  Scale  [24]  for  the  following  aspects:
selection  of  study  groups  (0—4  points);  comparability  of
groups  (0—3  points);  and  ascertainment  of  outcome  (0—6
points).  Disagreements  between  the  investigators  on  more
than  one  score  were  resolved  by  consensus.  Studies  with
a  total  of  more  than  10  points  (out  of  13)  were  consid-
ered  to  be  of  high  quality,  and  those  with  7—9  points  were
considered  to  be  of  good  quality.
Statistical analysis
To  compute  a  pooled  RR  and  its  95%  CI  for  the  highest  versus
lowest  category  of  dietary  ﬁbre  intake  from  original  stud-
ies,  we  combined  the  natural  logarithm  of  the  RRs  from
each  study,  using  the  DerSimonian  and  Laird  random-effects
models,  which  incorporate  both  within-  and  between-study
variations  [25].  For  studies  that  had  not  used  the  lowest  cat-
egory  as  a  reference,  the  RRs  and  95%  CIs  were  recalculated.
If  studies  provided  RRs  for  both  total  dietary  ﬁbre  intake  and
o
t
R
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ietary  ﬁbre  intake  from  each  food  source,  we  included  a  RR
or  total  dietary  ﬁbre  intake  in  the  main  analysis.  The  RRs  of
ietary  ﬁbre  intake  from  each  food  source  were  used  in  the
ubgroup  analyses  by  source  of  ﬁbre.  The  study-speciﬁc  RRs
s  well  as  a  pooled  RR  are  presented  as  forest  plots,  where
he  size  of  data  markers  (squares)  corresponds  to  the  inverse
f  variance  of  the  natural  logarithm  of  RR  from  each  study,
nd  a  diamond  indicates  a  pooled  RR.  We  assessed  statistical
eterogeneity  among  the  studies  using  the  Cochran  Q  statis-
ic  [26]  and  inconsistency  was  quantiﬁed  by  the  I2 statistic
27].
To  examine  dose-response  relationships  across  various
ategories  of  dietary  ﬁbre  intake,  we  used  a  generalized
east-squares  trend  estimation  analysis  based  on  the  method
eveloped  by  Greenland  and  Longnecker  [28—30]. After  esti-
ating  study-speciﬁc  slopes  from  the  correlated  natural
ogarithm  of  the  RRs  across  dietary  ﬁbre  categories  in  each
tudy  [12,15,18,19,22],  we  combined  the  generalized  least-
quares  trend-estimated  study-speciﬁc  slopes  with  studies
hat  reported  slope  estimates  [8—10,13,14,17,20,21]  to
erive  an  overall  average  slope.  If  the  studies  did  not
eport  mean  or  median  levels  of  dietary  ﬁbre  intake,  we
onsidered  the  midpoint  of  the  category  as  a  dose.  The
owest  and  highest  open-ended  categories  were  assumed
o  have  an  equal  interval  of  intake  as  the  adjacent  cate-
ory.  As  two  studies  did  not  report  the  number  of  deaths
r  person-time  across  dietary  ﬁbre  categories  [11,16],  a
otal  of  13  studies  were  included  in  the  dose-response
eta-analysis  for  CHD  mortality  [10,14,15,17,19—22],  CVD
ortality  [8—10,12,13,15,18,21]  and  all-cancer  mortality
13,18].
To evaluate  whether  the  pooled  RR  in  the  main  analysis
as  affected  markedly  by  a  single  study,  we  carried  out  a
ensitivity  analysis,  excluding  one  study  at  a  time.  We  also
erformed  subgroup  analyses  stratiﬁed  by  sex,  geographi-
al  region  (Europe/USA/others),  adjustment  for  covariates
age,  BMI,  smoking,  alcohol  and  physical  activity),  source
f  dietary  ﬁbre  (cereals/vegetables/fruits/legumes)  and
ater  solubility  (soluble/insoluble),  and  conducted  meta-
egression  analyses  to  test  for  variations  in  pooled  RRs
mong  the  subgroups.  Finally,  publication  bias  was  evalu-
ted  through  a funnel  plot  as  well  as  the  statistical  tests
f  Begg  and  Mazumdar  [31]  and  Egger  et  al.  [32].  A  two-
ailed  P-value  <  0.05  was  considered  statistically  signiﬁcant.
ll  statistical  analyses  were  performed  by  using  Stata/SE
oftware,  version  12.0  (Stata  Corporation,  College  Station,
X,  USA).
esults
tudy characteristics
e  identiﬁed  a  total  of  15  studies  from  12  cohorts  that
eported  RRs  of  dietary  ﬁbre  intake  and  mortality  from  CVD,
HD,  IHD  or  cancers  [8—22]  (Fig.  1).  The  main  characteris-
ics  of  the  studies  included  in  meta-analysis  are  presented
n  Table  1.  Six  studies  provided  RRs  of  mortality  from  CVD
nly  [8,9,11—13,18],  four  studies  provided  RRs  of  mor-
ality  from  CHD  only  [16,19,20,22],  two  studies  provided
Rs  of  IHD  only  [14,17]  and  three  studies  provided  RRs  of
ortality  from  both  CVD  and  CHD  [10,15,21].  Among  the
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Table  1  Characteristics  of  prospective  cohort  studies  included  in  the  meta-analysis  of  dietary  ﬁbre  intake  and  mortality  from  cardiovascular  disease,  coronary  heart
disease  or  all  cancers.
Reference  Study
location
Follow-up
period
(years)
Age at
baseline
(years)
Study  size  RR  (95%  CI)  Adjustment  factors
Subjects  (n)  Deaths  (n)  Fibre  category
(g/day)
Khaw  and
Barrett-
Connor,
1987  [17]
USAa 12  50—79  All:  859  IHD:  all:  65  Per  6  All:  0.79  (0.63,  0.98) Age,  systolic  BP,  cholesterol,  fasting
plasma  glucose,  BMI,  cigarette
smoking,  plus  oestrogen  use  (F  only)
M:  356  IHD:  M:  42  M:  0.85  (0.64,  1.11)
F:  503  IHD:  F:  23  F:  0.67  (0.45,  1.00)
<  16  vs  >  16  M:  0.33  (0.14,  0.77)  Age
F:  0.37  (0.11,  1.24)
Pietinen
et  al.,  1996
[19]
Finlandb 6.1  50—69  M:  21,930  CHD:  M:  635  16.1  1.00 Age,  smoking,  BMI,  BP,  intake  of
energy,  alcohol  and  saturated  fatty
acids,  education,  physical  activity,
intake  of  beta-carotene,  vitamin  C
and  vitamin  E
20.7  0.91  (0.72—1.15)
24.3  (0.83  0.64—1.06)
28.3  (0.72  0.55—0.93)
34.8  (0.73  0.56—0.95)
Wolk  et  al.,
1999  [22]
USAc 10  37—64  F:  68,782  CHD:  F:  162  11.5  1.00  Age
14.3  0.83  (0.52,  1.31)
16.4  0.74  (0.46,  1.18)
18.8  0.73  (0.46,  1.16)
22.9  0.41  (0.23,  0.70)
Bazzano
et  al.,  2003
[10]
USAd 19  25—74  9248  CHD:  668  <  7.7n 1.00 Age,  alcohol  intake,  BMI,  smoking,
education  level,  DM,  physical  activity,
sex,  race,  systolic  BP,  serum  total
cholesterol  concentration,  saturated  fat
intake,  total  calorie  intake
7.7—11.0n 0.87  (0.68,  1.12)
11.1—15.9n 0.79  (0.63,  0.99)
>  15.9n 0.85  (0.65,  1.10)
Per  10n 0.92  (0.84,  1.01)
CVD:  1198  <  7.7n 1.00
7.7—11.0n 0.95  (0.78,  1.15)
11.1—15.9n 0.84  (0.72,  0.97)
>  15.9n 0.93  (0.77,  1.12)
Per  10n 0.97  (0.93,  1.02)
Streppel
et  al.,
2008  [20]
Netherlandse 40  49  ±  6  M:  1373  CHD:  M:  348  Per  10  0.87  (0.71,  1.07)  Age,  total  intake  of  energy,  intake  of
saturated  fat,  trans  unsaturated  fatty
acids  and  cis  polyunsaturated  fatty
acids,  intake  of  alcohol,  wine  and  ﬁsh,
prescribed  diet,  number  of  cigarettes
smoked,  duration  of  cigarette
smoking,  cigar  or  pipe  smoking,  BMI,
socioeconomic  status
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Table  1 (Continue  )
Reference Study
location
Follow-up
period
(years)
Age at
baseline
(years)
Study  size RR (95%  CI) Adjustment  factors
Subjects  (n) Deaths  (n) Fibre  category
(g/day)
Kaushik
et  al.,  2009
[16]
Australiaf 13  ≥  49 2897  CHD:  NR Tertile  1:  3.0 0.94  (0.73,  1.22) Age,  sex,  systolic  BP,  diastolic  BP,  use  of
antihypertensives,  BMI,  smoking  status,
educational  qualiﬁcations,  fair  or  poor
self-rated  health,  history  of  MI  and
stroke,  DM,  energy  intake
Tertile  2:  6.5 1.22  (0.95,  1.58)
Tertile  3:  11.0 1.00
Eshak
et  al.,  2010
[15]
Japang 14.3  40—79 M:  23,119 CVD:  M:  1063 Q1:  M  <  7.8 M:  1.00 Age, BMI,  history  of  hypertension,  history
of  DM,  alcohol  intake,  smoking,
education  level,  hours  of  exercise,  hours
of  walking,  perceived  mental  stress,
sleep,  intake  of  ﬁsh,  saturated  fatty
acids,  (n-3)  fatty  acids,  sodium,  folate
and  vitamin  E
F:  35,611 CVD:  F:  1017 Q1:  F  <  8.5 F:  1.00
Q2:  M:  7.8—9.4 M:  1.06  (0.92,  1.22)
Q2:  F:  8.5—9.9 F:  1.21  (0.94,  1.44)
Q3:  M:  9.5—10.8 M:  0.92  (0.80,  1.06)
Q3:  F:  10.0—11.1 F:  1.06  (0.82,  1.19)
Q4:  M:  10.9—12.6 M:  0.86  (0.55,  1.55)
Q4:  F:  11.2—12.7 F:  0.85  (0.69,  0.99)
Q5:  M  >  12.6 M:  0.83  (0.63,  1.09)
Q5:  F  >  12.7 F:  0.82  (0.57,  0.97)
CHD:  231  M Q1:  M  <  7.8 M:  1.00
CHD:  484  F Q1:  F  <  8.5 F:  1.00
Q2:  M:  7.8—9.4 M:  0.83  (0.62,  1.12)
Q2:  F:  8.5—9.9 F:  1.03  (0.76,  1.48)
Q3:  M:  9.5—10.8 M:  0.69  (0.51,  0.93)
Q3:  F:  10.0—11.1 F:  0.86  (0.61,  1.13)
Q4:  M:  10.9—12.6 M:  0.59  (0.43,  0.81)
Q4:  F:  11.2—12.7 F:  0.81  (0.52,  0.99)
Q5:  M  >  12.6 M:  0.81  (0.61,  1.09)
Q5:  F  >  12.7 F:  0.80  (0.57,  0.97)
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Table  1  (Continue  )
Reference  Study
location
Follow-up
period
(years)
Age at
baseline
(years)
Study  size  RR  (95%  CI)  Adjustment  factors
Subjects
(n)
Deaths  (n)  Fibre  category
(g/day)
Buyken
et  al.,  2010
[12]
Australiaf 13  ≥  49  M:  1245  CVD:  M:  151  Tertile  1:  M:
18.4
M: 1.00 Age,  energy  intake,  total  ﬁbre  residuals,
dietary  glycaemic  index  residuals,  total
fat  intake,  whether  underweight,  current
smoking,  use  of  corticosteroid  drugs  at
baseline
F:  1490  CVD:  F:  109  Tertile  1:  F:
19.7
F: 1.00
Tertile  2:  M:
25.9
M: 0.74  (0.49,  1.13)
Tertile  2:  F:
24.8
F: 0.90  (0.55,  1.46)
Tertile  3:  M:
36.4
M: 0.84  (0.53,  1.34)
Tertile  3:  F:
36.2
F: 0.88  (0.53,  1.46)
Baer  et  al.,
2011  [9]
USAc 18  52.5  50,112  CVD:  1026  Per  4  0.82  (0.69,  0.97)  Age,  BMI,  weight  change  since  age  18
years,  height,  smoking  status,  smoking
amount/duration,  physical  activity,
alcohol  intake,  nut  consumption,
polyunsaturated  fat  intake,  glycaemic
load,  dietary  cholesterol,  systolic  BP,
use  of  antihypertensives,  personal
history  of  DM,  parental  MI  before  age
60  years,  time  since  menopause
Akbaraly
et  al.,
2011  [8]
UKh 18  49.5
(39—63)
6926  CVD:  141  Per  4.5  0.91  (0.74,  1.12)  Age,  modiﬁed  total  AHEI  score
excluding  the  component  considered
in  the  analysis,  sex,  ethnicity,
occupational  grade,  marital  status,
smoking  status,  total  energy  intake,
physical  activity,  BMI  categories,
prevalent  CVD,  type  2  DM,
hypertension,  dyslipidaemia,
metabolic  syndrome,  inﬂammatory
markers
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Table  1 (Continue  )
Reference  Study
location
Follow-up
period
(years)
Age  at
baseline
(years)
Study  size  RR  (95%  CI)  Adjustment  factors
Subjects  (n) Deaths  (n) Fibre  category
(g/day)
Park  et  al.,
2011  [18]
USAi 9  50—71 M:  219,123 CVD:  M:  5248 Q1:  M:  12.6 M:  1.00 Age,  race/ethnicity,  education,  marital
status,  health  status,  BMI,  physical
activity,  smoking  status,  time  since
quitting,  smoking  dose,  intake  of  alcohol,
red  meat  and  total  fruit/vegetables,
total  energy  intake
F:  168,999 CVD:  F:  2147 Q1:  F:  10.8 F:  1.00
Q2:  M:  16.4 M:  0.89  (0.82,  0.96)
Q2:  F:  14.3 F:  0.85  (0.75,  0.96)
Q3:  M:  19.4 M:  0.82  (0.75,  0.90)
Q3:  F:  17.0 F:  0.78  (0.68,  0.90)
Q4:  M:  22.9 M:  0.80  (0.73,  0.89)
Q4:  F:  20.1 F:  0.72  (0.61,  0.84)
Q5:  M:  29.4 M:  0.76  (0.68,  0.85)
Q5:  F:  25.8 F:  0.66  (0.55,  0.79)
Cancer:  M:  8244 Q1:  M:  12.6 M:  1.00
Cancer:  F:  4927 Q1:  F:  10.8 F:  1.00
Q2:  M:  16.4  M:  0.98  (0.91,  1.04)
Q2:  F:  14.3  F:  0.93  (0.85,  1.01)
Q3:  M:  19.4  M:  0.94  (0.87,  1.01)
Q3:  F:  17.0  F:  0.88  (0.80,  0.97)
Q4:  M:  22.9 M:  0.87  (0.81,  0.94)
Q4:  F:  20.1 F:  0.88  (0.79,  0.98)
Q5:  M:  29.4 M:  0.83  (0.76,  0.92)
Q5:  F:  25.8 F:  0.96  (0.85,  1.08)
Crowe
et  al.,  2012
[14]
Europej 11.5  40—85  306,331  IHD:  2381  <  17.5  1.00  Age,  alcohol  intake,  BMI,  physical
activity,  marital  status,  highest
education  level,  current  employment,
hypertension,  hyperlipidaemia,  angina
pectoris,  DM,  polyunsaturated  to
saturated  fat  ratio,  total  energy
intake
17.5—22.4 0.80  (0.71,  0.89)
22.5—27.4 0.78  (0.69,  0.89)
≥  27.5 0.77  (0.66,  0.89)
Per  10 0.85  (0.73,  0.99)
Chuang
et  al.,  2012
[13]
Europek 12.7  25∼70 M:  130,564 CVD:  M:  2489  <  16.4  M:  1.00  Age,  education,  smoking,  alcohol
intake,  BMI,  physical  activity,  total
energy  intake,  plus  anytime  use  of
menopausal  hormone  therapy  (F  only)
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Table  1  (Continue  )
Reference  Study
location
Follow-up
period
(years)
Age  at
baseline
(years)
Study  size  RR  (95%  CI)  Adjustment  factors
Subjects  (n)  Deaths  (n)  Fibre  category
(g/day)
F:  322,153  CVD:  F:  2115  F:  1.00
16.4  to  <  20.1  M:  0.91  (0.79,  1.03)
F:  0.83  (0.72,  0.95)
20.1  to  <  23.6  M:  0.82  (0.71,  0.94)
F:  0.80  (0.69,  0.93)
23.6  to  <  28.5  M:  0.81  (0.70,  0.94)
F:  0.73  (0.61,  0.86)
≥  28.5  M:  0.83  (0.71,  0.98)
F:  0.67  (0.55,  0.82)
Per  10  M:  0.84  (0.74,  0.94)
F:  0.79  (0.67,  0.94)
Cancer:  M:  4039  <  16.4  M:  1.00
Cancer:  F:  5575  F:  1.00
16.4  to  <  20.1  M:  0.93  (0.84,  1.03)
F:  0.88  (0.81,  0.95)
20.1  to  <  23.6  M:  0.84  (0.75,  0.93)
F:  0.92  (0.84,  1.00)
23.6  to  <  28.5  M:  0.92  (0.82,  1.03)
F:  0.90  (0.81,  0.99)
≥  28.5  M:  0.82  (0.72,  0.93)
F:  0.82  (0.73,  0.92)
Per  10  M:  0.91  (0.84,  0.99)
F:  0.86  (0.78,  0.95)
Threapleton
et  al.,  2013
[21]
UKl 14.3  51.8  F:  31,036  CHD:  F:  113  Q1:  21.0  1.00 Age,  BMI,  calories  from  carbohydrates,
fat  and  protein,  ethanol  intake,  METs
(1  kcal/kg/h),  smoking  status,
socioeconomic  status
Q2:  30.0  1.18  (0.68,  2.03)
Q3:  36.8  0.82  (0.43,  1.58)
Q4:  44.8  0.99  (0.52,  1.86)
Q5:  63.0  0.72  (0.28,  1.83)
Per  11  0.96  (0.73,  1.26)
CVD:  F:  230  Q1:  21.0  1.00
Q2:  30.0  0.84  (0.56,  1.25)
Q3:  36.8  0.62  (0.39,  0.98)
Q4:  44.8  0.72  (0.46,  1.13)
Q5:  63.0  0.61  (0.32,  1.17)
Per  11  0.91  (0.76,  1.08)
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Table  1 (Continue  )
Reference Study
location
Follow-up
period
(years)
Age  at
baseline
(years)
Study  size RR  (95%  CI) Adjustment  factors
Subjects
(n)
Deaths  (n) Fibre  category
(g/day)
Buil-
Cosiales
et  al.,  2014
[11]
Spainm 5.9  years M  (55—75) 7216  CVD:  103 Q1:  17 1.00 Age,  sex,  smoking  status,  DM,  BMI,
baseline  systolic  and  diastolic  arterial  BP,
intervention  group  use  of  statins,  alcohol
intake,  educational  level,  physical
activity,  total  energy  intake,  plus
stratiﬁcation  by  recruitment  centre
F  (60—75) Q2:  21 0.55  (0.31,  0.95)
Q3:  24 0.57  (0.32,  1.02)
Q4:  28 0.65  (0.35,  1.19)
Q5:  35 0.46  (0.23,  0.93)
Cancer:  169 Q1:  17 1.00
Q2:  21 0.67  (0.42,  1.06)
Q3:  24 0.78  (0.50,  1.23)
Q4:  28  0.59  (0.35,  0.98)
Q5:  35  0.69  (0.42,  1.14)
AHEI: alternative healthy eating index; BMI: body mass index; BP: blood pressure; CI: conﬁdence interval; CVD: cardiovascular disease; DM: diabetes mellitus; F: females; IHD: ischaemic
heart disease; M: males; METs: metabolic equivalents; MI: myocardial infarction; NR: not reported; RR: relative risk.
a Southern California population-based cohort.
b Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
c Nurses’ Health Study.
d National Health And Nutrition Examination Survey (NHANES) I epidemiological follow-up study.
e Zutphen Study.
f Blue Mountains Eye Study.
g Japan Collaborative Cohort Study.
h Whitehall II cohort.
i National Institutes of Health-American Association of Retired Persons (NIH-AARP) Diet & Health Study.
j European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart.
k EPIC.
l UK Women’s Cohort Study.
m Prevencion con Dieta Mediterranea (PREDIMED) Study.
n g/1735 kcal.
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Figure 1. Process used to select prospective cohort studies for a
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with  no  signiﬁcant  heterogeneity  (P  = 0.15,  I2 =  30.8%)eta-analysis of the association between dietary ﬁbre intake and
ortality from cardiovascular disease (CVD) and all cancers.
5  studies,  only  three  studies  reported  RRs  of  mortality
rom  all  cancers  [11,13,18].  By  geographical  region,  seven
tudies  were  conducted  in  Europe  [8,11,13,14,19—21],  ﬁve
n  the  USA  [9,10,17,18,22],  two  in  Australia  [12,16]  and
ne  in  Japan  [15].  The  follow-up  periods  ranged  from  5.9
o  40  years;  the  mean  follow-up  time  was  14.5  years.
he  age  of  the  subjects  ranged  from  20  to  85  years.
ost  of  the  studies  assessed  dietary  ﬁbre  intake  using
ood  frequency  questionnaires  [8,9,11—16,18,19,22],  while
wo  studies  used  24-hour  dietary  recall  [10,17]  and  one
tudy  used  a  cross-check  dietary  history  method  [20].  One
tudy  from  the  UK  assessed  dietary  ﬁbre  intake  using  both
ood  frequency  questionnaires  and  a  7-day  food  diary  [21].
ll  of  the  15  studies  adjusted  for  age  and  13  studies
djusted  for  BMI  [8—11,13—21]  or  smoking  [8—13,15—21].
en  studies  adjusted  for  alcohol  intake  [9—11,13—15,18—21]
r  physical  activity  [8—11,13—15,18,19,21].  With  regard
o  quality  assessment,  the  mean  quality  assessment  score
as  10  (range  8—13).  Six  studies  had  more  than  10
oints,  indicating  high  quality  [10,12,15—17,20];  the  other
ine  studies  had  8  or  9  points,  indicating  good  quality
8,9,11,13,14,18,19,21,22].
ighest versus lowest dietary ﬁbre intake
ietary ﬁbre intake and mortality from
ardiovascular disease
even  studies  were  included  in  the  analysis  for  the
ighest  versus  lowest  categories  of  dietary  ﬁbre  intake
(
t
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10—13,15,18,21].  The  pooled  RR  of  CVD  mortality  was
.77  (95%  CI:  0.71—0.84),  with  no  signiﬁcant  heterogeneity
mong  the  studies  (P  =  0.33,  I2 =  12.5%)  (Fig.  2A).  When  we
onducted  a  sensitivity  analysis  that  excluded  one  study  at
 time,  the  pooled  RRs  ranged  from  0.75  (95%  CI:  0.69,  0.80)
o  0.79  (95%  CI:  0.73,  0.86)  (data  not  shown).  The  results  of
ubgroup  analyses  by  study  characteristic  are  summarized
n  Table  2.  There  were  no  signiﬁcant  differences  by  sex,
eographical  region  or  water  solubility  (P:  0.1  for  all  com-
arisons).  When  the  analysis  was  limited  to  ﬁve  studies  that
djusted  for  age,  BMI,  smoking,  alcohol  and  physical  activity,
he  inverse  association  was  slightly  attenuated  (RR  =  0.81,
5%  CI:  0.72—0.92).  By  source  of  dietary  ﬁbre,  cereal  ﬁbre
ntake  was  strongly  associated  with  reduced  mortality  from
VD  (RR  =  0.77,  95%  CI:  0.71—0.82),  and  dietary  ﬁbre  intake
rom  legumes  also  showed  an  inverse  association  (RR  =  0.89,
5%  CI:  0.82—0.98).  On  the  other  hand,  vegetable  ﬁbre
RR  =  0.95,  95%  CI:  0.89—1.02)  and  fruit  ﬁbre  (RR  =  0.96,  95%
I:  0.83—1.11)  showed  no  signiﬁcant  inverse  associations.
he  differences  by  source  of  dietary  ﬁbre  were  all  statisti-
ally  signiﬁcant  (P  ≤  0.01  for  all  comparisons).
ietary ﬁbre intake and mortality from
oronary or ischaemic heart disease
ight  studies  that  provided  data  on  dietary  ﬁbre  intake  and
HD  mortality  [10,15,16,19,21,22]  or  IHD  mortality  [14,17]
ere  included  in  the  analysis  for  the  highest  versus  low-
st  categories  of  dietary  ﬁbre  intake.  The  pooled  RR  of
HD  or  IHD  mortality  was  0.76  (95%  CI:  0.67—0.87),  with
o  signiﬁcant  heterogeneity  (P  =  0.10,  I2 =  40.1%)  (Fig.  2B).  A
ensitivity  analysis  showed  that  the  pooled  RRs  ranged  from
.74  (95%  CI:  0.64—0.85)  to  0.79  (95%  CI:  0.71—0.88)  (data
ot  shown).  There  were  no  signiﬁcant  differences  by  sex,
eographical  region,  adjustment  for  covariates,  source  of
ietary  ﬁbre  or  water  solubility  (P  >  0.2  for  all  comparisons)
Table  2).
ietary ﬁbre intake and mortality from all
ancers
hree  studies  reported  data  on  dietary  ﬁbre  intake  and  all-
ancer  mortality  [11,13,18]. The  pooled  RR  was  0.86  (95%
I:  0.79—0.93),  with  no  signiﬁcant  heterogeneity  (P  =  0.14,
2 =  46%)  (Fig.  2C).  A  sensitivity  analysis  showed  that  the
ooled  RRs  ranged  from  0.82  (95%  CI:  0.77—0.88)  to  0.87
95%  CI:  0.75—0.99).  There  were  no  signiﬁcant  differences
y  sex  or  geographical  region  (P  >  0.4  for  all  comparisons)
data  not  shown).
ose-response meta-analysis
ietary ﬁbre intake and mortality from
ardiovascular disease
ight  studies  were  included  in  the  dose-response  meta-
nalysis  of  dietary  ﬁbre  intake  and  CVD  mortality
8—10,12,13,15,18,21]. The  pooled  RR  for  a  10  g/day  incre-
ent  in  dietary  ﬁbre  intake  was  0.91  (95%  CI:  0.88—0.94),Fig.  3A).  A  sensitivity  analysis  that  was  carried  out  by  omit-
ing  one  study  at  a  time  showed  the  pooled  RRs  ranging  from
.90  (95%  CI:  0.87—0.93)  to  0.91  (95%  CI:  0.89—0.94)  (data
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Table  2  Pooled  relative  risks  of  mortality  from  cardiovascular  disease  and  coronary  heart  disease  according  to  dietary
ﬁbre  intake  in  a  meta-analysis  of  prospective  cohort  studies.
Variable  CVD  mortality  CHD  mortality
No.  of
studies
RR  95%  CI  P  for
difference
No.  of
studies
RR 95%  CI  P  for
difference
High  versus  low  ﬁbre  intake
All  studies  7  0.77  0.71,  0.84  8  0.76  0.67,  0.87
Sex
Male  4  0.79  0.72,  0.86  0.14  3  0.70  0.52,  0.95  0.71
Female  5  0.70  0.62,  0.78  4  0.60  0.39,  0.92
Region
Europe  3  0.71  0.59,  0.86  3  0.76  0.67,  0.86
USA  2  0.77  0.65,  0.91  0.46a 3  0.52  0.28,  0.98  0.40a
Others  2  0.83  0.70,  0.98  0.27a 2  0.85  0.73,  1.00  0.53a
Adjustment  for
age,  BMI,
smoking,  alcohol
and  physical
activity
Yes 5  0.81 0.72,  0.92 0.245  4  0.79  0.69,  0.91  0.65
No  2  0.74 0.67,  0.81 4  0.65  0.46,  0.91
Source  of  ﬁbre
Cereals  3  0.77  0.71,  0.82  5  0.83  0.76,  0.92
Vegetables  3  0.95  0.89,  1.02  0.001b 4  0.90  0.79,  1.02  0.46b
Fruits  3  0.96  0.83,  1.11  <  0.001b 4  0.68  0.49,  0.95  0.34b
Legumes  2  0.89  0.82,  0.98  0.01b 1  1.33  0.65,  2.72  0.29b
Water  solubility
Soluble  2  0.85  0.75,  0.96  0.4  4  0.73  0.62,  0.85  0.54
Insoluble  2  0.77  0.66,  0.90  3  0.66  0.52,  0.83
10  g/day  increment  in  ﬁbre  intake
All  studies  8  0.91  0.88,  0.94  8  0.89  0.85,  0.93
Sex
Male  4  0.91  0.88,  0.94  0.82  4  0.89  0.84,  0.95  0.96
Female  5  0.90  0.84,  0.97  4  0.85  0.74,  0.98
Region
Europe  3  0.89  0.78,  1.01  4  0.92  0.87,  0.97
USA  3  0.89  0.86,  0.93  0.83a 3  0.87  0.79,  0.96  0.40a
Others  2  0.95  0.89,  1.01  0.37a 1  0.80  0.70,  0.92  0.14a
Adjustment  for
age,  BMI,
smoking,  alcohol
and  physical
activity
Yes  5  0.91  0.85,  0.96  0.86  5  0.91  0.86,  0.96  0.12
No  3  0.90  0.87,  0.93  3  0.83  0.75,  0.91
5  g/day  increment  in  ﬁbre  intake
Source  of  ﬁbre
Cereals  4  0.94  0.90,  0.98  5  0.95  0.89,  1.01
Vegetables 3  0.92  0.89,  0.95  0.57b 5  0.92  0.86,  0.98  0.43b
Fruits  3  0.96  0.90,  1.01  0.5b 5  0.89  0.73,  1.10  0.92b
Legumes  1  0.87  0.68,  1.13  0.63b 2  0.90  0.78,  1.03  0.56b
Water  solubility
Soluble  3  0.87  0.74,  1.02  0.8  4  0.83  0.71,  0.98  0.93
Insoluble  2  0.92  0.85,  1.00  3  0.83  0.71,  0.98
BMI: body mass index; CHD: coronary heart disease; CI: conﬁdence interval; CVD: cardiovascular disease; RR: relative risk.
a P-value for the difference in RRs (when all geographical regions — Europe, USA and others — were included in the meta-regression
model, simultaneously).
b P-value for the difference in RRs (when all sources of dietary ﬁbre — cereals, vegetables, fruits and legumes — were included in the
meta-regression model, simultaneously).
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Figure 2. Forest plot of prospective cohort studies of (A) cardiovascular disease mortality, (B) coronary heart disease mortality and (C)
all-cancer mortality for the highest versus lowest category of dietary ﬁbre intake, using a random-effects model. CI: conﬁdence interval;
F: females; M: males; RR: relative risk.
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Figure 3. Forest plot of prospective cohort studies of (A) cardiovascular disease mortality, (B) coronary heart disease mortality and (C)
all-cancer mortality for an increment of 10 g/day in dietary ﬁbre intake, using a random-effects model. CI: conﬁdence interval; F: females;
M: males; RR: relative risk.
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ot  shown).  The  differences  by  sex,  geographical  region,
djustment  for  covariates,  source  of  dietary  ﬁbre  or  water
olubility  were  not  statistically  signiﬁcant  (P  >  0.3  for  all
omparisons).
ietary ﬁbre intake and mortality from
oronary or ischaemic heart disease
ight  studies  reported  RRs  of  dietary  ﬁbre  intake  and  mortal-
ty  from  CHD  or  IHD  [10,14,15,17,19—22]. The  pooled  RR  for
 10  g/day  increment  in  dietary  ﬁbre  intake  was  0.89  (95%
I:  0.85—0.93),  and  there  was  no  signiﬁcant  heterogeneity
mong  the  studies  (P  =  0.28,  I2 =  18.2%)  (Fig.  3B).  A sensitiv-
ty  analysis  showed  that  the  pooled  RRs  ranged  from  0.88
95%  CI:  0.83—0.93)  to  0.90  (95%  CI:  0.86—0.94)  (data  not
hown).  The  pooled  RRs  did  not  differ  by  sex,  geographical
egion,  adjustment  for  covariates,  source  of  dietary  ﬁbre  or
ater  solubility  (P  >  0.1  for  all  comparisons)  (Table  2).
ietary ﬁbre intake and mortality from all
ancers
wo  studies  provided  RRs  of  dietary  ﬁbre  intake  and  all-
ancer  mortality  [13,18].  The  pooled  RR  for  a  10  g/day
ncrement  in  dietary  ﬁbre  intake  was  0.94  (95%  CI:
.91—0.97),  with  no  signiﬁcant  heterogeneity  (P  = 0.17,
2 =  44.3%)  (Fig.  3C).  A  sensitivity  analysis  showed  that  the
ooled  RRs  ranged  from  0.93  (95%  CI:  0.87—0.98)  to  0.95
95%  CI:  0.93—0.97).  The  differences  by  sex  or  geograph-
cal  region  were  not  statistically  signiﬁcant  (P  >  0.3  for  all
omparisons)  (data  not  shown).
ublication bias
here  was  no  indication  of  publication  bias  for  the  meta-
nalysis  of  the  highest  category  of  dietary  ﬁbre  intake  versus
he  lowest  (Begg  and  Mazumdar:  P  >  0.1;  Egger  et  al.:  P  >  0.1
or  mortality  from  CVD,  CHD  and  all  cancers).  For  the  dose-
esponse  meta-analysis  of  CVD  and  all-cancer  mortality,
here  was  no  evidence  of  publication  bias  (Begg  and  Mazum-
ar:  P  >  0.6;  Egger  et  al.:  P  >  0.4).  For  the  dose-response
eta-analysis  of  CHD  mortality,  however,  there  was  some
vidence  of  publication  bias  based  on  the  test  of  Egger  et  al.
P  =  0.03),  but  not  the  test  of  Begg  and  Mazumdar  (P  =  0.12).
iscussion
n  the  current  systematic  review  and  meta-analysis,  the
ssociation  between  dietary  ﬁbre  intake  and  mortality  from
VD,  CHD  and  all  cancers  was  explored  through  15  prospec-
ive  cohort  studies  with  1,409,014  subjects.  We  found  that
ietary  ﬁbre  intake  is  inversely  associated  with  mortality
rom  CVD,  CHD  and  all  cancers.  Overall,  participants  who
ad  a  high  intake  of  dietary  ﬁbre  (mean  ∼29.6  g/day  for  CVD
ortality,  ∼23.2  g/day  for  CHD  mortality  and  ∼30.4  g/day
or  all-cancer  mortality)  had  a  reduction  in  CVD  mortal-
ty  by  23%,  CHD  mortality  by  24%  and  all-cancer  mortality
y  14%,  respectively,  compared  with  those  who  had  a  low
ntake  of  dietary  ﬁbre  (mean  ∼14.0  g/day  for  CVD  mor-
ality,  ∼12.5  g/day  for  CHD  mortality  and  ∼15  g/day  for
ll-cancer  mortality).  The  dose-response  meta-analyses  also
ndicated  that  a  10  g/day  increment  in  dietary  ﬁbre  intake
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as  inversely  associated  with  a  reduction  in  mortality  from
VD  by  9%,  from  CHD  by  11%  and  from  all  cancers  by  6%.
here  was  no  signiﬁcant  heterogeneity  among  the  studies.
imilar  inverse  associations  were  found  by  sex,  geographical
egion,  water  solubility  and  adjustment  factors  (age,  BMI,
moking,  alcohol  and  physical  activity).  By  source  of  dietary
bre,  cereal  ﬁbre  consistently  showed  a  signiﬁcant  inverse
ssociation  with  CVD  mortality  both  in  the  highest  versus
owest  analysis  and  in  a  dose-response  analysis.  By  water
olubility  of  dietary  ﬁbre,  similar  inverse  associations  were
ound,  but  the  number  of  studies  included  in  the  analysis
as  limited.
Accumulating  evidence  from  epidemiological  studies  sug-
ests  that  higher  dietary  ﬁbre  intake  is  associated  with  a
educed  risk  of  CVD  [6]  and  CHD  [6,33,34]. These  studies
eported  that  cereal  ﬁbre  had  a  stronger  inverse  associ-
tion  with  risks  of  CVD  [6]  and  CHD  [34]  than  the  other
ources  of  ﬁbre,  and  these  ﬁndings  are  consistent  with  our
esults.  The  one  meta-analysis  that  mainly  examined  the
ncidence  of  CHD  and  dietary  ﬁbre  intake  also  reported  some
esults  for  CHD  death  as  an  outcome  (i.e.  a  27%  lower  risk
f  CHD  death  in  people  who  had  a high  dietary  ﬁbre  intake
ersus  those  who  had  a  low  intake)  [34]. Our  present  meta-
nalysis  of  dietary  ﬁbre  intake  and  CVD  and  CHD  mortality
ncluded  studies  that  the  previous  meta-analysis  did  not
nclude  [8,9,11—14,16—18,21].
Several  studies  have  also  shown  an  inverse  association
etween  high  dietary  ﬁbre  intake  and  risk  of  gastric  [35],
reast  [36]  and  pancreatic  cancer  [37].  Furthermore,  one
tudy  reported  that  a  10  g/day  increment  in  dietary  ﬁbre
ntake  was  inversely  associated  with  a  reduction  in  colorec-
al  cancer  mortality  by  33%  [38].
An  inverse  association  between  dietary  ﬁbre  intake  and
iseases  such  as  CVD  or  cancer  may  be  explained  by  sev-
ral  mechanisms.  Dietary  ﬁbre  has  some  beneﬁcial  effects
n  cardiovascular  health  by  lowering  serum  cholesterol  con-
entrations  via  an  increase  in  the  excretion  of  bile  acids  in
aeces  [39]  and  inhibiting  fatty  acid  synthesis  in  the  liver
hrough  the  production  of  short-chain  fatty  acids  resulting
rom  fermentation  [40]. Dietary  ﬁbre  may  also  help  to  con-
rol  body  weight  because  of  its  slower  digestion  and  greater
atiety  [41]. One  meta-analysis  reported  that  dietary  ﬁbre
ntake  reduces  systolic  and  diastolic  blood  pressure  [42]  by
ecreasing  body  weight  [43],  which  could  be  a  risk  factor  for
ypertension  and  obesity.  In  addition,  high  consumption  of
ietary  ﬁbre  has  been  associated  with  a  reduced  risk  of  type
 diabetes  by  increasing  insulin  sensitivity  [44].  As  hypercho-
esterolaemia,  hypertension,  obesity  and  type  2  diabetes
re  all  major  risk  factors  for  CVD  [3], and  dietary  ﬁbre  is
nversely  associated  with  inﬂammatory  markers  [45]  that
re  important  for  the  progression  of  CVD  and  cancer,  high
ietary  ﬁbre  intake  may  decrease  deaths  from  CVD  or  cancer
y  slowing  down  the  progression  of  these  diseases.
tudy strengths and limitations
he  present  meta-analysis  has  several  strengths.  To  the
est  of  our  knowledge,  this  is  the  ﬁrst  comprehensive
eta-analysis  of  dietary  ﬁbre  intake  and  CVD,  CHD  and
ll-cancer  mortality  that  included  a  large  number  of  sub-
ects  (n  =  1,409,014)  from  the  general  population  who  had  no
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[Dietary  ﬁbre  and  mortality  from  cardiovascular  disease  and  
speciﬁc  diseases.  We  included  only  prospective  cohort  stud-
ies  in  the  current  analysis,  so  the  possibility  of  recall  or
selection  bias  that  can  affect  the  results  could  be  minimal.
Many  studies  included  in  the  meta-analysis  had  a  relatively
long  duration  of  follow-up  (mean  of  ∼14.5  years)  from  var-
ious  geographical  regions.  The  results  of  quality  assessment
suggested  that  all  of  the  studies  included  in  the  meta-
analysis  were  of  high  or  good  quality.  Furthermore,  we  found
a  signiﬁcant  dose-response  relationship  between  dietary
ﬁbre  and  CVD,  CHD  or  all-cancer  mortality,  and  there  was
no  signiﬁcant  evidence  of  heterogeneity  among  the  studies
included  in  the  meta-analysis.
The  current  study  also  has  several  limitations  that  should
be  acknowledged.  First,  a  meta-analysis  cannot  solve  the
problem  of  confounding  factors  that  might  exist  in  the  orig-
inal  studies.  People  who  consume  high  dietary  ﬁbre  tend  to
have  other  healthy  behaviours,  such  as  higher  levels  of  phys-
ical  activity,  avoidance  of  tobacco  use  and  low  alcohol  intake
[13,15,18,46].  The  majority  of  studies  included  in  this  meta-
analysis  adjusted  for  potential  confounding  factors,  such  as
BMI,  smoking,  alcohol  and  physical  activity,  and  the  inverse
association  between  dietary  ﬁbre  and  CVD  or  CHD  remained
signiﬁcant  even  in  the  analysis  stratiﬁed  by  the  adjustment
for  covariates.  Nonetheless,  there  is  still  a  possibility  that
unknown  and/or  residual  confounding  may  have  inﬂuenced
the  results  in  each  study,  and  thus  the  pooled  estimates  in
the  meta-analysis.  Second,  some  non-differential  misclassi-
ﬁcation  of  self-reported  dietary  ﬁbre  intake  is  inevitable,  as
most  of  the  studies  included  in  our  meta-analysis  assessed
dietary  ﬁbre  intake  using  a  food  frequency  questionnaire  at
a  single  timepoint  only.  The  possible  misclassiﬁcation,  how-
ever,  would  probably  have  biased  the  results  toward  the  null,
rather  than  strengthening  the  association  between  dietary
ﬁbre  intake  and  CVD  or  all-cancer  mortality.  Third,  results  of
subgroup  analyses  in  the  current  meta-analysis  were  based
on  a  limited  number  of  studies,  although  the  relatively  large
sample  size  of  this  study  allowed  us  to  conduct  subgroup
analyses.  Lastly,  publication  bias,  such  as  small-study  effect,
can  be  of  concern  in  meta-analyses.  In  our  meta-analysis,
there  was  weak  evidence  of  publication  bias  based  on  the
test  of  Egger  et  al.  in  the  dose-response  analysis  of  CHD
mortality.
Conclusions
In  conclusion,  our  meta-analysis  of  15  prospective  cohort
studies  indicates  that  high  ﬁbre  intake,  especially  ﬁbre
from  cereals,  is  signiﬁcantly  associated  with  lower  mortal-
ity  from  CVD,  CHD  and  all  cancers.  Although  it  is  difﬁcult  to
determine  causality  of  this  association  because  of  the  obser-
vational  nature  (i.e.  consumption  of  ﬁbre  is  self-selected,
not  randomized),  large  prospective  data,  adjustment  for
important  confounders,  consistency  with  results  from  pre-
vious  publications  and  a  trend  towards  a  dose-response
relationship  with  dietary  ﬁbre  intake  may  suggest  real  pro-
tection  from  dietary  ﬁbre  against  death  from  CVD,  CHD  and
all  cancers.  Our  results  support  the  current  recommendation
that  high  dietary  ﬁbre  intake  should  be  part  of  a  healthy
diet.  More  prospective  cohort  studies,  which  fully  adjust
for  potential  confounders  and  conduct  subgroup  analyses  by
source  of  dietary  ﬁbre,  should  be  performed  to  verify  the
[er  53
ssociation  between  dietary  ﬁbre  intake  and  CVD,  CHD  and
ll-cancer  mortality.
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